Example: Heart Attack

Clinical Trials on Purpura

Total 364 results

NCT04562766

Not yet recruiting

Ph3 Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

Conditions: Immune Thrombocytopenia
NCT04518475

Recruiting

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Conditions: Primary Immune Thrombocytopenia (ITP)
NCT04518878

Recruiting

Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)

Conditions: Immune Thrombocytopenia
NCT04516837

Recruiting

Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

Conditions: Immune Thrombocytopenia
NCT04516967

Not yet recruiting

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Conditions: Immune Thrombocytopenia
NCT04481282

Recruiting

The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04428255

Not yet recruiting

A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP

Conditions: Primary Immune Thrombocytopenic Purpura
NCT04387942

Recruiting

The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 in Children With Henoch-schönlein Purpura

Conditions: Purpura, Schoenlein-Henoch
NCT04368598

Recruiting

The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP

Conditions: Immune Thrombocytopenia
NCT04346654

Recruiting

A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

Conditions: Immune Thrombocytopenia (ITP)
NCT04323748

Not yet recruiting

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenic Purpura
NCT04320225

Not yet recruiting

Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04311593

Not yet recruiting

Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenia
NCT04289207

Not yet recruiting

Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04278924

Recruiting

Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Persistent/Chronic Primary Immune Thrombocytopenia

Conditions: Primary Immune Thrombocytopenia
NCT04274452

Withdrawn

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia (ITP)
NCT04224688

Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia
NCT04225156

Recruiting

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Conditions: Primary Immune Thrombocytopenia
NCT04217148

Recruiting

The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04214951

Recruiting

A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

Conditions: Corticosteroid-resistant or Relapsed ITP
NCT04200456

Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia
NCT04188379

Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Conditions: Primary Immune Thrombocytopenia
NCT04132050

Recruiting

A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

Conditions: Idiopathic Thrombocytopenic Purpura
NCT04128358

Not yet recruiting

Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?

Conditions: Idiopathic Thrombocytopenic Purpura
NCT04113915

Not yet recruiting

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

Conditions: ITP - Immune Thrombocytopenic Purpura; Viral Hepatitis
NCT04102033

Not yet recruiting

Eltrombopag in Chronic ITP

Conditions: Immune Thrombocytopenia
NCT04100876

Not yet recruiting

Effect of DNMT SNPs on DNA Methylation in Primary ITP

Conditions: Primary Immune Thrombocytopenia
NCT04094805

Not yet recruiting

A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP

Conditions: Immune Thrombocytopenia
NCT04089267

Completed

Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)

Conditions: ITP
NCT04083014

Recruiting

Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia; Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
NCT04074187

Recruiting

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Conditions: Thrombotic Thrombocytopenic Purpura
NCT04070599

Completed

Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.

Conditions: Immune Thrombocytopenic Purpura; Autoimmune Thrombocytopenia; Thrombopenia
NCT04070612

Completed

National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.

Conditions: Cytopenia; Autoimmune Haemolytic Anaemia; Thrombocytopenic Purpura, Immune
NCT04071496

Completed

Diagnostic of Chronic Thrombocytopenia

Conditions: Congenital Thrombocytopenia; Chronic Idiopathic Thrombocytopenic Purpura
NCT04057703

Completed

Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.

Conditions: Immune Thrombocytopenic Purpura; Autoimmune Hemolytic Anemia; Evan Syndrome; Immunotherapy
NCT04056195

Recruiting

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Conditions: Immune Thrombocytopenia
NCT04056507

Completed

Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenic Purpura; Splenectomy; Status
NCT04039477

Withdrawn

A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP

Conditions: Autoimmune Hemolytic Anemia; Immune Thrombocytopenia
NCT04021173

Not yet recruiting

A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Conditions: Acquired Thrombotic Thrombocytopenic Purpura
NCT04014166

Recruiting

Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia

Conditions: Thrombocytopenia; Mesenchymal Stem Cells
NCT04014413

Recruiting

Safety and Efficacy of Fecal Microbiota Transplantation

Conditions: Crohn Disease; Ulcerative Colitis; Celiac Disease; Irritable Bowel Syndrome; Functional Dysphonia; Constipation; Clostridium Difficile Infection; Diabetes Mellitus; Obesity; Multidrug -Resistant Infection; Hepatic Encephalopathy; Multiple Sclerosis; Pseudo-Obstruction; Carbapenem-Resistant Enterobacteriaceae Infection; Vancomycin Resistant Enterococci Infection; Multiple Organ Dysfunction Syndrome; Dysbiotic Bowel Syndrome; MRSA Enteritis; Pseudomembranous Enterocolitis; Alopecia; Autism; Graft-versus-host Disease; Idiopathic Thrombocytopenic Purpura; Atopy or Allergy; Liver Disease; Alcohol Dependence; Psoriatic Arthropathy
NCT04005638

Recruiting

Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

Conditions: Immune Thrombocytopenia; Autoimmune Hemolytic Anemia; Autoimmune Neutropenia
NCT04003220

Not yet recruiting

Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker

Conditions: Thrombocytopenia; Purpura, Thrombocytopenic; Myelodysplastic Syndromes
NCT03998982

Recruiting

Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

Conditions: Immune Thrombocytopenia
NCT03998059

Recruiting

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Conditions: Thrombocytopenia; Splenectomy
NCT03975361

Not yet recruiting

Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)

Conditions: Immune Thrombocytopenia (ITP); Systemic Lupus Erythematosus (SLE)
NCT03965624

Withdrawn

Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia

Conditions: Immune Thrombocytopenia; Warm Autoimmune Hemolytic Anemia
NCT03951623

Recruiting

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

Conditions: Immune Thrombocytopenia (ITP)
NCT03939637

Recruiting

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Conditions: Immune Thrombocytopenia
NCT03922308

Recruiting

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Conditions: Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

COOKIE SETTINGS

Clinical Trials on Purpura